Gross profit · 2011–2025

Sinovac Biotech gross profit

$262M+18.7% · FY2025

Sinovac Biotech (SVA) reported $262M in gross profit for fiscal 2025, +18.7% year on year.

$35.7M2011$30.1M2012$51.3M2013$47.5M2014$49.0M2015$50.0M2016$154M2017$205M2018$214M2019$443M2020$18.4B2021$815M2022$323M2023$221M2024$262M2025
Sinovac Biotech — Gross profit, 2011–2025
Fiscal yearGross profitChangeFiling
FY20252025-12-31$262M+18.7%Open →
FY20242024-12-31$221M−31.7%Open →
FY20232023-12-31$323M−60.3%Open →
FY20222022-12-31$815M−95.6%Open →
FY20212021-12-31$18.4B+4,044.0%Open →
FY20202020-12-31$443M+107.6%Open →
FY20192019-12-31$214M+4.2%Open →
FY20182018-12-31$205M+33.0%Open →
FY20172017-12-31$154M+208.0%Open →
FY20162016-12-31$50.0M+2.1%Open →
FY20152015-12-31$49.0M+3.3%Open →
FY20142014-12-31$47.5M−7.4%Open →
FY20132013-12-31$51.3M+70.2%Open →
FY20122012-12-31$30.1M−15.7%Open →
FY20112011-12-31$35.7M—Open →

Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +15.3%

Gross profit at companies of similar size

Full ranking by gross profit →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Sinovac Biotech gross profit |url=https://companiesranked.com/en/company/sinovac-biotech/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Sinovac Biotech gross profit. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/gross-profit

BibTeX

@misc{companiesranked-en-company-sinovac-biotech-gross-profit-2026,
  author       = {{CompaniesRanked}},
  title        = {{Sinovac Biotech gross profit}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/gross-profit}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026

{{cite web |title=Sinovac Biotech gross profit — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Sinovac Biotech overview